首页> 外文会议>Asia-Pacific Congress on Catalysis >New Enantioselective Chiral Imidazolidine Liands for Pd-Catalazed Asymmetric Allylic Alkylation
【24h】

New Enantioselective Chiral Imidazolidine Liands for Pd-Catalazed Asymmetric Allylic Alkylation

机译:新的对映选择性手性手性咪唑胺LianDS用于PD-催化的不对称烯丙基烷基化

获取原文

摘要

During the last decade, various enantioselective catalysts have been developed for palladium-catalyzed allylic substitution reactions. In particular, chiral phosphinooxazoline ligands are one of the effective ligands in this reaction. The design of efficient chiral ligands is essential for asymmetric allylic alkylation (AAA) and has become one of the most intense areas of investigation. A series of C_2-symmetric diphosphines such as chiraphos, DIOP and BINAP, which gave high enantioselectivities in asymmetric hydrogenation, have been used in early study. However, in contrast with five-membered oxazolines, the chiral imidazolines or imidazolidines have not been extensively studied as ligands to date. Because the combination of an imidazolidine group with an auxiliary donor atom provides the different electronic and sterie environment around the metal, we have prepared new ligands containing both the imidazolidine moiety and an auxiliary S or P donor.
机译:在过去十年中,已经开发了各种对映选择性催化剂用于钯催化的烯丙基取代反应。特别地,手性磷酶唑啉配体是该反应中的有效配体之一。高效手性配体的设计对于不对称烯丙基烷基化(AAA)至关重要,并且已成为最强烈的调查领域之一。早期研究,已经使用了一系列C_2-对称二膦,例如在不对称氢化中发出高对映射性的肾上腺素,DioP和Binap。然而,与五元月桂蛋白相比,手性咪唑啉或咪唑啉迄今未被广泛地研究作为配体。因为咪唑烷基与辅助供体原子的组合提供了金属周围的不同电子和静脉环境,所以我们制备了含有咪唑烷部分和助剂的新配体和助剂或POTOR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号